NewAmsterdam Pharma Co N.V. — All Filings
379 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
20-F
20-F/A
3
3/A
4
424B3
424B5
425
6-K
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
EFFECT
F-1
F-1/A
F-3
F-4
F-4/A
POS AM
PRE 14A
S-3
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-104239 | Mar 12, 2026 | Mar 11, 2026 |
| 144 | — | 0001968582-26-000272 | Mar 11, 2026 | — |
| 4 | 4 | 0001193125-26-100798 | Mar 10, 2026 | Mar 6, 2026 |
| 4 | 4 | 0001193125-26-099073 | Mar 9, 2026 | Mar 5, 2026 |
| 144 | — | 0001968582-26-000241 | Mar 6, 2026 | — |
| 144 | — | 0001968582-26-000230 | Mar 5, 2026 | — |
| 4 | 4 | 0001193125-26-085947 | Mar 2, 2026 | — |
| 8-K | 8-K | 0001193125-26-084266 | Mar 2, 2026 | — |
| 144 | — | 0001968582-26-000187 | Mar 2, 2026 | — |
| 4 | 4 | 0001193125-26-078718 | Feb 26, 2026 | Feb 24, 2026 |
| 4 | 4 | 0001193125-26-067260 | Feb 24, 2026 | Feb 20, 2026 |
| 144 | — | 0001968582-26-000152 | Feb 24, 2026 | — |
| 144 | — | 0002085929-26-000002 | Feb 20, 2026 | — |
| 10-K | 10-K | 0001193125-26-056029 | Feb 18, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-056020 | Feb 18, 2026 | — |
| S-8 | S-8 | 0001193125-26-056037 | Feb 18, 2026 | — |
| SCHEDULE 13G/A | — | 0000905148-26-000880 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0000315066-26-000486 | Feb 5, 2026 | — |
| 4 | 4 | 0001193125-26-029526 | Jan 29, 2026 | Jan 27, 2026 |
| 4 | 4 | 0001193125-26-025012 | Jan 27, 2026 | Jan 23, 2026 |
| 4 | 4 | 0001193125-26-019686 | Jan 22, 2026 | Jan 20, 2026 |
| 144 | — | 0001968582-26-000040 | Jan 20, 2026 | — |
| 4 | 4 | 0001193125-26-009269 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | 4 | 0001193125-26-009268 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | 4 | 0001193125-26-009273 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | 4 | 0001193125-26-009270 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | 4 | 0001193125-26-009271 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | 4 | 0001193125-26-009274 | Jan 9, 2026 | Jan 7, 2026 |
| 4 | 4 | 0001193125-26-009272 | Jan 9, 2026 | Jan 7, 2026 |
| 8-K | 8-K | 0001193125-26-008300 | Jan 9, 2026 | — |
| 4 | 4 | 0001193125-26-006662 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006659 | Jan 7, 2026 | Jan 5, 2026 |
| 144 | — | 0001974494-26-000023 | Jan 7, 2026 | — |
| 4 | 4 | 0001193125-26-006658 | Jan 7, 2026 | Jan 5, 2026 |
| 144 | — | 0001968582-26-000015 | Jan 6, 2026 | — |
| 144 | — | 0001974494-26-000017 | Jan 5, 2026 | — |
| 144 | — | 0001974494-26-000013 | Jan 5, 2026 | — |
| 144 | — | 0001974494-26-000015 | Jan 5, 2026 | — |
| 4 | 4 | 0001193125-25-335513 | Dec 29, 2025 | Dec 23, 2025 |
| 144 | — | 0001968582-25-001282 | Dec 23, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-308141 | Dec 4, 2025 | — |
| 144 | — | 0001193125-25-305717 | Dec 2, 2025 | — |
| 144 | — | 0001193125-25-305720 | Dec 2, 2025 | — |
| 144 | — | 0000950130-25-000295 | Dec 2, 2025 | — |
| SCHEDULE 13G/A | — | 0001422849-25-000077 | Nov 13, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-272748 | Nov 7, 2025 | — |
| 8-K | 8-K | 0001193125-25-265800 | Nov 5, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-265796 | Nov 5, 2025 | Sep 30, 2025 |
| SCHEDULE 13D/A | — | 0001231919-25-000416 | Nov 4, 2025 | — |
| SCHEDULE 13D/A | — | 0001193125-25-225170 | Sep 30, 2025 | — |